Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
吉非替尼抑制 DNA-PK 可导致吉非替尼与顺铂在 NSCLC 中产生协同作用
期刊:International Journal of Oncology
影响因子:4.5
doi:10.3892/ijo.2020.5103
Chi Pan #, Huijie Duan #, Yinan Wu, Chunpeng Zhu, Chenghao Yi, Yin Duan, Demin Lu, Cheng Guo, Deqi Wu, Yanyan Wang, Xianhua Fu, Jing Xu, Yiding Chen, Meng Luo, Wei Tian, Tao Pan, Wenhong Xu, Suzhan Zhang, Jianjin Huang